Sorry you missed out - Stay updated for next years show here!

The Exhibition Hall Program

We are pleased to introduce The Innovation Stage in the exhibition hall, putting the spotlight on cutting-edge technology and award winning case-studies to address the multiple challenges and opportunities in the pharmaceutical industry.

The Innovation stage will host short, sharp presentations. These include some of the most innovative companies working in areas covering design thinking, VR/AR, Gamification, Blockchain, Genomics, Behavioural Science, AI/Machine Learning and Chatbots.

Free Exhibition Pass Access Times:

Conference Sessions: 2:00pm - 6:00pm | Networking drinks: 6:00pm - 7:00pm

Innovation Stage – Case Study Quick Fire

1:50pm - 1:55pm

Chairperson’s Opening Address

1:55pm - 2:10pm

Using data modelling and machine learning to provide real-time information and guidance
  • How ALK improved allergy patients’ lives with the first personalised allergy companion app, using data modelling and machine-learning to provide real-time information and guidance
eyeforpharma Awards Case Study Finalist - Most Valuable Patient Initiative

Louise Kristine Hjernø

Head of Digital Projects

ALK

2:10pm - 2:25pm

Non-adherence in Diabetes: finding ways to improve patient compliance
  • Find out how big data analytics on internet search behaviors can be used to segment the population on potential non-compliance factors
  • Discover how behavioral profiling can support recommendations on how to address the non-compliance risks specific to each segment

Maurice Straetmans

Vice President Healthcare Industries

Tsquared Insights

2:25pm - 2:40pm

How to empower patients and improve conversations with HCPs
  • See how Novartisand Health Unlimited built an online digital community Speak Your Migraine to improve patient-HCP relationships
eyeforpharma Awards Case Study Finalist - Most Valuable Patient Initiative

Dimitra Mastrantoni

WorldWide Associate Brand Director Migraine

Novartis

Brendan Manning

Account Director

Health Unlimited

2:40pm - 3:00pm

Reimburse digital solutions - lessons learnt from Germany’s most successful reimbursement case study
  • Understand how Sonormed successfully gained market access for Germany’s first health product mobile app before it’s even been developed
  • Explore the payer negotiation process and hear feedback from reimbursement considerations shaping product development

Jörg Land

CEO

Sonormed

The Interactive Roundtables

2:00pm - 3:00pm

Commercial Roundtables
  1. How Pharma can go beyond the pill to provide value-added services
  2. Enable reps to deliver more immersive education with VR tools
  3. Beyond education: become a source of inspiration for HCPs
  4. Customer Experience: measure yourself against the hardest metrics, including loyalty and advocacy
  5. Remove complexity with smarter KAM and MSL coordination
  6. The Biologics revolution - impact on health and the economy
  7. Gender Parity in Action: from Awareness to Outcomes

Roundtable facilitators include:

  • Dr Munna Choudhury, Independent Consultant affiliated with Accenture and Alacramed
  • Tim Cave, CEO & Founder, SaySo Medical
  • Cyril Mandry, Senior Marketing Director, MSD
  • Guido Senatore, Country Medical Director Spain, Bayer
  • Anita Natzkova, Strategic Insights Lead Global Pharmaceutical, Abbott
  • Ingrid Marchal-Gerez, Regional President, Marketing & Communications, Healthcare Businesswomen's Association

3:05pm - 4:10pm

Interactive Workshops – Pharma and Bio Companies attendees only

Each of the below interactive sessions will take place concurrently between 3:05pm – 4:10pm as break-outs from the main agenda (there will be no other talks at this time). Every session will bring together 15-30 pharma and biotech attendees alongside the hosts to deep dive into the particular topic specified below.

These sessions will be the biggest chance at the event to interact, debate and share experiences with your fellow attendees and expert session leaders.

  1. Developing excellence in AI Led by Novasecta
  2. Evolving HCP websites: deliver behaviour changing journeys rather than digital destinations Led by EPG Health
  3. Understand and act on HCP channel preference in the “orchestrated customer environment” - key trends and success factors Led by IQVIA Technologies
  4. Connected content: how to create content beyond systems, channels and devices Led by Viseven Europe
  5. End-to-End processes with Intelligent Automation Led by Appian
  6. The rules of patient engagement: Building trust across the globe Led by Snow Companies, Shire, UCB & Catherine Irwin (Patient speaker)
  7. Use case: Transform real-world data (RWD) into patient care improvement Led by Cegedim
  8. Create better alignment between sales and marketing teams to win the modern customer Led by Showpad
  9. Live Interactive Experience: How digital is revolutionising patient journeys Led by Deloitte & Deloitte ConvergeHealth

4:10pm - 4:40pm

Coffee Break

Coffee and snacks are available to purchase in the expo hall

4:40pm - 4:50pm

Creating a patient-centric artificial intelligence (AI) communication chatbot to improve patient support
  • Understand how Norgine used AI to develop a patient chatbot Ava to provide timely, accessible information to support patients
eyeforpharma Awards Case Study Finalist - Most Valuable Patient Initiative

Kym Jacks-Bryant

Global Digital Marketing Lead

Norgine

Veronique Segura

Global Brand Manager

Norgine

Hannah Thompson

Senior Central Medical Affairs Executive

Norgine

4:56pm - 5:10pm

What is a spider without its web or how one company embraced digital transformation
  • Find out how to transform your communication with HCPs through integration of offline and online activities
  • See how to achieve 9 points of contact per month with HCPs through customized digital content
  • Discover how to multiply the effect of your activities by integrating a single digital solution targeting both HCPs and patients

Alexandra Veleva

CEO

Credoweb

4:40pm - 5:40pm

Technology Roundtables
  1. The power of digital health innovation in increasing value to patients and HCPs - are you there yet?
  2. Empowering Patients through data

Roundtable facilitators include:

  • Cristina De Juan, CEO & Founder, IMT Innovation
  • Caroline Schmitt, Medical Science Liaison, Takeda
Market Access Focused Roundtables
  1. Patient + value = payer value: how to articulate new patient journey understanding into a language payers understand
  2. Monopoly vs. Monopsony: risks and opportunities for companies and payers/health systems in joint value assessments and negotiations in Europe
  3. Italy’s outcomes-based experience: deep dive into the challenges and key learnings from the early movers into outcomes-based agreements in Europe
  4. Internal access alignment: discuss how best to pool capabilities and define Market Access responsibilities
  5. Cost containment and affordability barriers across European markets: new trends in market access

Roundtable facilitators include:

  • Agathe le Lay, Director and Head of Health Economics & Outcomes Research, Lundbeck
  • Thomas Temme, Head of Value Demonstration & Access & Public Affairs Germany, Austria & Switzerland, Shire Pharmaceuticals
  • Lara Pippo, Head of Market Access, CSL Behring
  • Ben Wheatley, Associate Director, Four Health
  • Neil Chin-On, Head of Market Access Pharmaceuticals, Novartis

5:10pm - 5:25pm

How a start up medtech has improved the lives of cystic fibrosis patients with remote data
  • Learn from a pioneering approach to cystic fibrosis care via remote data collection from NuvoAirthat has reduced hospital visits and improved patient outcomes
eyeforpharma Awards Case Study Finalist - Most Valuable Patient Initiative

Lorenzo Consoli

Co-Founder, CEO

NuvoAir

Fredrik Aidehag

Director of Products

NuvoAir

5:25pm - 5:40pm

eyeforpharma Awards Winner - Most Valuable HCP Initiative Case Study

6:00pm - 7:00pm

Networking Drinks in the Exhibition Hall
Free Exhibition Pass Access Times:

Conference Sessions: 9:00am - 5:30pm | Networking drinks: 5:30pm - 7:00pm

Innovation Stage – Innovation you need

9:00am - 9:10am

Chairperson’s Opening Address

9:10am - 9:30am

The first biopharma company to be born in the cloud
  • Understand how Moderna Therapeutics has evolved as a truly digital biopharma organization and what this means for advancing drug candidates to clinical studies; increasing the agility of its research, development, and manufacturing processes; and achieveing results—such as personalized cancer vaccines—that would have been impossible even a few years ago.
  • Lessons learnt from their journey and their vision for the future of the company and what this means for the future pharma business model

Marcello Damiani

CDO

Moderna Therapeutics

9:30am - 9:50am

From the Ward to the World: the potential of remote patient monitoring in digital medicine
  • Understand the real-world patient journey and response to treatment through remote patient monitoring
  • Emphasise the importance of providing good quality data to pharmaceutical partner
  • Identify emerging trends within digital medicine and Medopad’s approach to navigating this space

Martha Carruthers

Head of Pharma Partnerships

Medopad

9:50am - 10:30am

PANEL: Beyond the pill: How digital therapeutics can drive market access innovation and herald in a new era of shared value
  • Discuss how the current partnership model is flawed and why we need to be partnering for new kinds of value
  • Find out how the leading organizations are partnering by focusing on the friction and pain points of care, and building value alliances with key stakeholders

David Van Sickle

CEO

Propeller Health

Matthew Bonam

Head of Intelligent Pharmaceuticals

AstraZeneca

The Interactive Roundtables

9:00am - 10:30am

Design Thinking Workshop

Accelerate innovation by addressing patient and company challenges with design thinking Learn how aspects of design thinking can be applied to generate solutions and solve even the most complex problems in the healthcare environment. Think beyond digital, ensuring your organisation utilises new technology and ways of thinking to enhance the patient journey. Envisage how other industries and companies have embedded design thinking within their organisation, which allows for continuous feedback and improvements to products and services

Roundtable facilitators include:

  • Ute Conradi, Head of the innovation hub “Creative Lab“ / Sr. Lead Operational Excellence, UCB
Procurement Roundtables
  1. Deliver, prove and maximise ROI on your digital spend
  2. Procurement as the digital trasnformation catalyst

Roundtable facilitators include:

  • Filiz Saka Crockford, Commercial Procurement Category Lead, Takeda

 

10:30am - 11:00am

Coffee Break

Coffee and snacks are available to purchase in the expo hall

11:00am - 11:20am

From ‘sickcare’ to healthcare: AI and the future of personalised care
  • Understand how AI can support the shift from reactive ""sickcare"" to the delivery of more people-centric, proactive health management and care
  • Learn how AI-enabled tools will empower the individual to more effectively manage their health
  • Preview how AI can support the earlier identification, prevention and management of chronic and rare disease.

Daniel Nathrath

Founder & Chief Executive Officer

Ada Health

11:20am - 11:30am

Beyond automation: How Connected Robotic Process Automation (RPA) can improve efficiency, outcomes, and patient relationships
  • RPA is empowering business users to make transformational change without the cost and complexity associated with technology-led projects
  • Imagine how highly-efficient Digital Workers collaborating seamlessly with humans could improve outcomes for your technicians, clinicians, managers, and patients
  • Understand how you can leverage this Intelligent Automation, the combined power of enterprise RPA and class-leading artificial intelligence, to enhance business and clinical processes

Drew Sonden

Partner Solutions Consultant EMEA

Blue Prism

11:30pm - 11:50pm

Scale Behavioral Change To Leave No Patient Behind
  • Design effective patient programs through personalized behavioural triggers
  • Apply predictive analytics to create patient segments
  • Build the infrastructure for an RWE strategy capable of informing tailored programs at scale

Jennifer Turgiss

Vice President, Behavior Science & Advanced Analytics

Johnson & Johnson Health and Wellness Solutions

11:50am - 12:50pm

Interactive Workshops – Pharma and Bio Companies attendees only

Each of the below interactive sessions will take place concurrently between 11:40am – 12:50pm as break-outs from the main agenda (there will be no other talks at this time). Every session will bring together 15-30 pharma and biotech attendees alongside the hosts to deep dive into the particular topic specified below.

These sessions will be the biggest chance at the event to interact, debate and share experiences with your fellow attendees and expert session leaders.

  1. Deliver on multichannel's potential: a smarter way to do marketing production Led by Williams Lea Tag
  2. A glimpse behind the curtain: Optimize your digital engagement using real-world customer behavior Led by McCANN Health
  3. Mobilizing AI and machine learning for commercial success in Europe Led by IQVIA
  4. Live Interactive Experience: How digital is revolutionising patient journeys Led by Deloitte & Deloitte ConvergeHealth
  5. Boost HCP multi-channel communication with improved AI application Led by antwerpes AG
  6. Novartis Case Study: STOP Fixing & START Coaching! Led by Novartis & Atomus
  7. Beyond the Talk: How do you enable multidisciplinary teams to confront internal & external challenges to be able to innovate and ultimately be MORE PATIENT? Led by Frontera
  8. How Analytics and Artificial Intelligence can help you to get the right treatment to patients at the right time Led by McKinsey
  9. Unlocking the business model in Connected health Led by Phillips Medisize

12:50pm - 1:50pm

Lunch Break

Lunch is available to purchase in the expo hall

1:50pm - 2:10pm

Training our immune system to prevent and cure chronic diseases.
  • Understand that the prevention and management of chronic diseases should focus not only on symptomatic patients but on individuals that do not yet have symptoms.
  • Discuss how this disease-prevention strategy profoundly impacts clinical development, marketing and distribution of products, and new payor models.
  • Appreciate how digital strategies that affect an individual’s behaviour towards lifestyle choices, can enhance adherence to treatment and positively affect clinical outcome

Oliver Siegel

CEO

AFFiRiS

2:10pm - 2:20pm

Speed up patient recruitment using AI and Natural Language Processing
  • Up to 50% of Clinical Trials are delayed due to patient recruitment issues.
  • Unstructured text-based Medical Records hold around 85% of patients' clinical information.
  • Discover how IOMED helps you leverage the power of detailed patient data to speed up patient recruitment.

Javier de Oca Catalán

CEO

IOMED Medical Solutions Healthtech

2:20pm - 2:40pm

How single-cell transcriptomics will redefine human diseases and unearth novel therapeutic avenues
  • Everything you need to know about The Human Cell Atlas, an ambitious project, funded by the Chan-Zuckerberg Institute and others, to map every cell in the human body and how this could impact how drugs are developed
  • Learn how the single revolution is rewriting our understanding of a human disease ranging from cancer to inflammatory conditions

Hussein Al-Mossawi

Clinical Leader, Rheumatology

Oxford University

2:40pm - 3:00pm

Fireside chat

Rachel Haurwitz

CEO

Caribou Bio

1:50pm - 3:10pm

Im-patient Roundtables
  • Creating inclusion across country, language, culture and ethnic barriers – the evolution of patient story telling
  • How to improve ethnic representation in clinical trials
  • Discuss best and worst case examples of pharma-patient group collaboration
  • Disjointed relationship between pharma and med-tech and impact on patient lives
  • An in-depth look at the efforts made in pain management and how we can better create access to physical therapies
  • The changing space of patient advocacy/organisation corporate responsibility (CR) as influence, regulation and onlookers increase
  • Building an experience-based framework to accelerate the growth/improve chances of success for start-up patient groups and organisations
  • It’s raining digital applications – increase use through more targeted collaborative effort, driven by patient need

Roundtable facilitators include:

  • Rick Harris, Patient Advocate & Ellly
  • Henny van Zuidland -Ordelman, Patient & Advocate
  • Alan Thomas, Ataxia & ME
  • Andrew Spiegel, IAPO
  • Carole Sian Scrafton, Fibro Flutters
  • Linda van de Vliert-Duijts, Patient & Advocate
  • Birgit Bauer, Patient & Advocate

3:10pm - 3:40pm

Coffee Break

Coffee and snacks are available to purchase in the expo hall

3:40pm - 4:00pm

What commercial pharma needs to know about blockchain
  • Blockchain is about more than cryptocurrencies – it enables multiple parties to jointly collaborate and transact in near real-time
  • Records in the blockchain are encrypted and linked, addressing the heightened safety and privacy concerns that come with personalized care, patient registries & GDPR

Ben Taylor

CEO

LedgerDomain

4:00pm - 4:20pm

Two ways that blockchain can transform pharma
  • Live demo of a global supply chain application that passes medication from manufacturers to suppliers to patients – this not only sets the stage to drive down out-of-stocks and counterfeits, but also the advent of personalized medicines
  • Clinical study supply chains managed through blockchain make it possible to replace paper without compromising security or double-blind requirements
  • Blockchain-based patient registries can provide safe and secure sandbox for AI, machine learning on aggregated data sets.

Ben Taylor

CEO

LedgerDomain

4:20pm - 4:40pm

An industry interface into Population Genomics at scale
  • The Genomic Medicine Future: How to balance industry requirements with other key stakeholder groups who also have a critical role to play in preparing healthcare systems
  • Hear a definition and key characteristics of population genomics programmes
  • See examples from across EMEA – including operational features
  • Understand what the industry requirements are
  • Leave with an understanding of “What works well?” and “even better if …” from a leading expert in population genomics programmes

Paul Jones

Director, Population Genomics

Illumina

3:40pm - 4:40pm

Field Force Effectiveness Taskforce Roundtables

Explore the evolution of pharma’s medical and commercial field force in a fast-changing external environment:
In an hour-long interactive session hosted by field force leaders understand emerging capability requirements, measure effectiveness and ensure successful interactions

Roundtable facilitators include:

  • Heather Moses, Head of Medical Affairs, Roche
  • Dirk Abeel, Global Medical Sales Director, Reckitt Benckiser, Inc.
  • Chris Keenan, Head, Worldwide Medical Customer Engagement, Medical Capabilities, BMS

4:40pm - 5:00pm

Genomics and Blockchain: Decentralized genomic big data storage, sharing and analysis
  • Look into the future state of genomic data sharing and security as new technological advancements at the intersection of healthcare and information technology are developed.
  • Describe how blockchain technology can enable genomic data creation, ensure its security, and allow for its sharing
  • Discuss the future state of genomic research, genomic data security, genomic data standardization and data sharing between individuals and companies as whole genome sequencing costs continue to decrease.

Dennis Grishin

Co-Founder

Nebula Genomics

5:00pm - 5:20pm

The Digitome: The first digital representation of health and disease
  • Understand the Human Digitome Project: Including the long-term vision for the platform and how it will be opened it up so that anyone can proactively use it themselves to enable researchers to understand more about how diseases work, and how to cure them.
  • How AI is being used to look for patterns in the ways patients contract diseases and react to medication, to give doctors more information about people’s health
  • How blockchain enables patient-centric data

Michelle Longmire

CEO

Medable

5:20pm - 7:00pm

Networking Drinks in the Exhibition Hall
Day 3…